Skip to content

Drug interactions

Bortezomib + Fosphenytoin

Severity: Major

Bortezomib and Fosphenytoin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosphenytoin is converted to phenytoin, a CYP3A4 inducer that may lower bortezomib exposure. This may reduce anti-myeloma efficacy.

What this interaction means in plain words

Bortezomib and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bortezomib belongs to Oncology; Fosphenytoin belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Induction of CYP3A4-mediated bortezomib metabolism.

What to do

Avoid strong inducers where possible and use a non-inducing anticonvulsant. If it cannot be avoided, monitor disease response closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Fosphenytoin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Fosphenytoin?

MediHelp rates the interaction as major. Bortezomib and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Fosphenytoin is converted to phenytoin, a CYP3A4 inducer that may lower bortezomib exposure. This may reduce anti-myeloma efficacy.

How serious is the interaction between Bortezomib and Fosphenytoin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid strong inducers where possible and use a non-inducing anticonvulsant. If it cannot be avoided, monitor disease response closely.

What other medicines interact with Bortezomib?

MediHelp also lists interactions of Bortezomib with, for example, Apalutamide, Carbamazepine, Etrasimod. The full list is on the Bortezomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in